Featured Research

from universities, journals, and other organizations

New infant formula ingredients boost babies' immunity by feeding their gut bacteria

Date:
February 29, 2012
Source:
University of Illinois College of Agricultural, Consumer and Environmental Sciences
Summary:
Adding prebiotic ingredients to infant formula helps colonize the newborn's gut with a stable population of beneficial bacteria, and probiotics enhance immunity in formula-fed infants, two studies report.

Adding prebiotic ingredients to infant formula helps colonize the newborn's gut with a stable population of beneficial bacteria, and probiotics enhance immunity in formula-fed infants, two University of Illinois studies report.

"The beneficial bacteria that live in a baby's intestine are all-important to an infant's health, growth, and ability to fight off infections," said Kelly Tappenden, a U of I professor of nutrition and gastrointestinal physiology. "Breast-fed babies acquire this protection naturally. Formula-fed infants get sick more easily because the bacteria in their gut are always changing."

The idea is to make formula more like breast milk by promoting the sorts of intestinal bacteria that live in breast-fed babies' intestines, she added.

Prebiotics are carbohydrates that resist digestion by human enzymes and stimulate the growth and activity of beneficial bacteria in the gastrointestinal tract.

Probiotics are actual live bacteria that are beneficial to intestinal health, she said.

Infants have a special need for stimulation of their gut microbiota because they are born with a sterile intestine, Tappenden said.

"A strong, robust population of microbes in the gut provides colonization resistance, and pathogens can't invade and infect an infant who has that resistance as easily," she added.

The researchers compared the effects of feeding pre- and probiotics with infants fed breast milk and control formulas. They also compared the enhanced formulas' effects in both vaginally and Caesarean-delivered babies.

"The probiotic formula significantly enhanced immunity in formula-fed infants," Tappenden said.

Also, babies delivered by C-section had an especially improved immune response, an important finding because C-section babies are a more vulnerable group, she said.

Why? "Babies delivered naturally are exposed to the mother's bacteria as they travel through the birth canal, and they develop a healthier population of gut bacteria as a result. Babies delivered by C-section enter a sterile environment, and their gut microbiota is quite different," Tappenden noted.

In the probiotics study, scientists at five sites divided 172 healthy six-week-old infants into two formula-fed groups and a breast-fed group. Beginning at six weeks of age, the formula-fed groups received either a control formula or a formula that contained the beneficial bacteria Bifidobacterium animalis subspecies lactis (Bb12) for a six-week period. The infants receiving the probiotic formula had increased concentrations of secretory, anti-rotavirus, and anti-poliovirus-specific immunoglobulin A (IgA).

Fecal samples from babies receiving the probiotic formula revealed significantly heightened immunity, especially among Caesarian-delivered infants, Tappenden said.

Infants who consumed the formula containing the prebiotic ingredients also benefited. In that study, 139 healthy babies were divided into three groups. Breast-fed infants were compared with babies fed either a control formula or a formula supplemented with galacto- and fructo-oligosaccharides for six weeks.

Oligosaccharides, found in breast milk, contribute to the healthy population of bacteria found in the guts of breast-fed infants.

When fecal samples were tested, babies fed the prebiotic formula showed modest improvement in the number of beneficial bacteria and decreases in the types of bacteria that are often associated with illness.


Story Source:

The above story is based on materials provided by University of Illinois College of Agricultural, Consumer and Environmental Sciences. Note: Materials may be edited for content and length.


Journal References:

  1. H. D. Holscher, K. L. Faust, L. A. Czerkies, R. Litov, E. E. Ziegler, H. Lessin, T. Hatch, S. Sun, K. A. Tappenden. Effects of Prebiotic-Containing Infant Formula on Gastrointestinal Tolerance and Fecal Microbiota in a Randomized Controlled Trial. Journal of Parenteral and Enteral Nutrition, 2012; 36 (1 Suppl): 95S DOI: 10.1177/0148607111430087
  2. H. D. Holscher, L. A. Czerkies, P. Cekola, R. Litov, M. Benbow, S. Santema, D. D. Alexander, V. Perez, S. Sun, J. M. Saavedra, K. A. Tappenden. Bifidobacterium lactis Bb12 Enhances Intestinal Antibody Response in Formula-Fed Infants: A Randomized, Double-Blind, Controlled Trial. Journal of Parenteral and Enteral Nutrition, 2012; 36 (1 Suppl): 106S DOI: 10.1177/0148607111430817

Cite This Page:

University of Illinois College of Agricultural, Consumer and Environmental Sciences. "New infant formula ingredients boost babies' immunity by feeding their gut bacteria." ScienceDaily. ScienceDaily, 29 February 2012. <www.sciencedaily.com/releases/2012/02/120229155540.htm>.
University of Illinois College of Agricultural, Consumer and Environmental Sciences. (2012, February 29). New infant formula ingredients boost babies' immunity by feeding their gut bacteria. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/02/120229155540.htm
University of Illinois College of Agricultural, Consumer and Environmental Sciences. "New infant formula ingredients boost babies' immunity by feeding their gut bacteria." ScienceDaily. www.sciencedaily.com/releases/2012/02/120229155540.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins